文献速递神经肿瘤

昼夜节律生物学在脑肿瘤诊断与治疗中的应用

Circadian biology in brain cancer diagnosis and treatment.
PubMed 文献 · Neuro Oncol · 2026-10-08

本文综述了昼夜节律生物学在胶质母细胞瘤(GBM)生长、诊断和治疗中的作用。GBM细胞基因表达和化疗敏感性呈现每日节律,昼夜节律治疗策略包括扰乱肿瘤细胞节律、阻断其与宿主同步或寻找活检、手术、放疗、化疗的最佳时间。文章讨论了一项正在进行的替莫唑胺时辰治疗试验,并建议在500多项活跃GBM临床试验中评估和控制昼夜节律。

要点

  • GBM细胞基因表达和化疗敏感性存在每日节律
  • 昼夜节律治疗策略包括扰乱肿瘤节律或寻找最佳治疗时间
  • 建议在GBM临床试验中评估和控制昼夜节律

核心结论

  • 昼夜节律生物学在GBM诊断和治疗中具有潜在应用价值,应考虑将脑肿瘤整合到宿主昼夜节律系统中。
  • 是时候在脑癌患者护理中评估和控制昼夜节律了。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • GBM是最常见且致命的原发性脑癌,中位生存期为15个月。
  • 过去20年反复努力引入延长生命的疗法,但标准治疗几乎没有变化。
  • 近期研究表明GBM细胞在基因表达和化疗敏感性方面表达每日节律。
  • 癌症的标志性特征常显示每日变化。
  • 昼夜节律治疗策略包括扰乱GBM细胞的每日节律、阻断其与宿主的同步,或寻找活检、手术、放疗或化疗的最佳时间。

临床怎么用

  • 考虑在活检、手术、放疗或化疗时选择最佳时间以利用昼夜节律。
  • 在GBM临床试验中评估和控制昼夜节律。

局限性

  • 近期有反对时辰治疗的证据,需批判性评估GBM中的时间效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioblastoma (GBM), the most common and lethal primary brain cancer, has a median survival of 15 months. Despite repeated efforts over 20 years to introduce life-extending therapies, little has changed in the standard of care. Recent studies have revealed that GBM cells express daily rhythms in gene expression and sensitivity to chemotherapy. In this review, we highlight the role of circadian biology in GBM growth, and its potential applications to GBM diagnosis and treatment. The hallmarks of cancer often show daily variation. We emphasize opportunities to advance our understanding of glioblastoma pathophysiology by considering how brain tumors integrate into the host circadian system and respond to daily rhythms in neuronal, paracrine, or hormonal signals to promote growth. Circadian treatment strategies include disrupting daily rhythms in GBM cells, blocking their synchronization to the host, or finding best times of day for biopsy, surgery, radiation, or chemotherapy. We discuss an ongoing temozolomide chronotherapy trial in the context of recent evidence against chronotherapy and suggest ways to critically assess time-of-day effects in GBM. With over 500 active clinical trials for GBM, it is time to evaluate, and control for, circadian rhythms in care for brain cancer patients. Brain cancers are difficult to cure because tumors may not be fully removed without harming critical brain functions, drugs struggle to reach the brain, and the brain environment weakens immune responses. New treatment strategies are urgently needed. Recent research shows that neurons influence how tumors grow, leading to a new field called cancer neuroscience. However, the role of the body’s internal clock has been largely overlooked. Our review explores how time of day affects brain tumor diagnosis, growth, and treatment response, with the goal of delivering therapies when tumors are most vulnerable to improve effectiveness and reduce side effects.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Salvatore SV, Kaval AM, Gibson EM, et al. Circadian biology in brain cancer diagnosis and treatment. Neuro Oncol. 2026. PMID: 42844996. doi:10.1093/neuonc/noag179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。